Bilkent Holding Felisya Biomedical A.Ş., an innovative biomedical company focused on public health, has developed a system called "Diagnovir" for the testing and diagnosis of the Kovid-19 virus by Turkish researchers. The clean rooms, where this nanotechnology-based system, which can diagnose Kovid-19 with 99 percent reliability in 10 seconds, was produced, was delivered in 2021.